Gland Pharma shares jump 4% as Q2 profit jumps 58%, revenue rises 23% YoY
Economic Times
Gland Pharma shares rose nearly 4% after the company reported a 58% increase in Q2 net profit and a 23% rise in revenue.
Shares of Gland Pharma climbed 3.89% to Rs 3,254.60 in Monday's trading session following a strong financial performance for the September 2026 quarter. The pharmaceutical company registered a 23% year-on-year increase in revenue from operations, reaching Rs 1,834 crore compared to Rs 1,487 crore in the previous year. Additionally, net profit surged by 58%, and the stock touched a fresh 52-week high of Rs 3,345 during the day.
Why it matters: The strong financial results drove Gland Pharma's stock price to a new 52-week high, reflecting positive market sentiment toward the company's growth.





